











My project was a continuation of the Vascular Research Lab’s (VRL) ongoing research 
at the University of Tennessee Medical Center Knoxville (UTMCK) aimed at optimizing 
liposomal encapsulation efficiency of small interfering RNA (siRNA) which can be used 
to silence genes to prevent a variety of disease pathologies.
Methods: 
• Assay siRNA loading capacity of liposomes based on lipid concentration 
• Development of a method for liposome purification 
o HPLC
o HiTRAP Column 
Results & Conclusion:
• siRNA loading capacity 
o Higher lipid:siRNA resulted in increased encapsulation efficiency
• HPLC – did not work as expected 






• Small interfering RNA (siRNA)
oUsed to silence genes to prevent disease pathologies
§ i.e. Intimal hyperplasia development & atherosclerotic plaque 
formation 
• Liposomal delivery of siRNA 
oEmerging field
omany approaches: utilize cationic synthetic lipids to promote siRNA 
encapsulation within the liposomal nanoparticles
§ Immunogenicity & cytotoxicity hinders translational success 
• VRL is working to develop an assembly technique to optimize 
siRNA encapsulation into liposomal nanoparticle
oComprised of neutral, naturally occurring phospholipids 




siRNA Loading Capacity of 
Liposomes
• Analysis was based on lipid concentration
• Varying lipid-to-siRNA weight-to-weight ratios were 
used at assembly from 2.5:1 to 100:1
• The resulting siRNA encapsulation was quantified by 
RiboGreen
• A fluorescent assay 
• nucleotide residues are fluorescently labeled for detection
• By denaturing formed liposomes and labeling 
entrapped siRNA, this would give a linear output so 
that the unknown sample’s fluorescence could be 
easily related to a concentration along a standard 
curve.  
Liposomal Purification
• High performance liquid chromatography (HPLC)
o size exclusion chromatography column (SEC) was used to separate                     
formed liposomes from free siRNA based on their differential size.  
§ Separation should take place over 30-45 min
o By collecting the HPLC liposome fraction before siRNA elution, the                
liposomes could be denatured and assayed by RiboGreen as before.  
• HiTRAP Column 
o packed with Phenyl Sepharose High Performance material
§ strong cation exchange resin 
§ can selectively retain anionic nucleotide residues of the siRNA
o liposomes could be manually pushed through the column 
o the siRNA was retained within the resin
o The siRNA must then be manually eluted in a second step.








siRNA Loading Capacity of Liposomes Results
• loading capacity of siRNA is directly 
related to lipid content
o not siRNA availability




o not an automated one-step system such 
as HPLC
o manual process
o Rapid purification method 
o can be performed in <60 minutes with 
accurate resolution
o has the potential for scalability 
o is being further optimized in the VRL for 
implementation in their standard 
operating procedures.
• HPLC
o did not work as planned
o liposomal nanoparticles formed are 
<65nm in diameter 
o The SEC column resolution was not 
specific enough to accurately 
separate free siRNA from the 
nanoparticles
o HPLC peaks were overlapped and 
the collection fractions could not be 
accurately resolved.
Conclusions
My research project was a continuation of the VRLs 
ongoing research aimed at optimizing liposomal encapsulation 
efficiency of small interfering RNA (siRNA).  siRNA can be used to 
silence genes to prevent a variety of disease pathologies, 
including intimal hyperplasia development and atherosclerotic 
plaque formation, the pathologies of primary interest in the VRL. 
Liposomal delivery of siRNA is an emerging field in biomedical 
engineering and research. The standardization of liposomal 
encapsulation could help other laboratories utilize liposomal 
siRNA delivery in their own areas of research and promote more 






Various methods were used to optimize liposomal 
encapsulation efficiency:
1. Assay siRNA loading capacity of liposomes based on lipid 
concentration
• Higher lipid:siRNA resulted in increased encapsulation efficiency 
2. Purification of liposomes 
a) HPLC
• Did not work as expected 
• SEC column was not specific enough to separate free siRNA from 
nanoparticles 
b) HiTRAP Column 
• Successful
• Now under further testing to optimize it to be used as part of standard 
operating procedures going forward
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